264 related articles for article (PubMed ID: 37546394)
1. Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma.
You J; Xia H; Huang Z; He R; Zhao X; Chen J; Liu S; Xu Y; Cui Y
Front Oncol; 2023; 13():1204715. PubMed ID: 37546394
[TBL] [Abstract][Full Text] [Related]
2. Serum long noncoding RNA LRB1 as a potential biomarker for predicting the diagnosis and prognosis of human hepatocellular carcinoma.
Wang ZF; Hu R; Pang JM; Zhang GZ; Yan W; Li ZN
Oncol Lett; 2018 Aug; 16(2):1593-1601. PubMed ID: 30008842
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
[TBL] [Abstract][Full Text] [Related]
4. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
5. Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation.
Zhou J; Zhu Y; Li Y; Liu K; He F; Xu S; Li X; Li L; Hu J; Liu Y
Infect Agent Cancer; 2021 May; 16(1):28. PubMed ID: 33971914
[TBL] [Abstract][Full Text] [Related]
6. Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma.
Han Y; Jiang W; Wang Y; Zhao M; Li Y; Ren L
BMC Cancer; 2022 Apr; 22(1):431. PubMed ID: 35443674
[TBL] [Abstract][Full Text] [Related]
7. Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma.
Chen T
J Hepatocell Carcinoma; 2022; 9():1029-1040. PubMed ID: 36132427
[TBL] [Abstract][Full Text] [Related]
8. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
9. Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring.
Shaik MR; Sagar PR; Shaik NA; Randhawa N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445822
[TBL] [Abstract][Full Text] [Related]
10. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
Kim SS; Baek GO; Ahn HR; Sung S; Seo CW; Cho HJ; Nam SW; Cheong JY; Eun JW
Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LINC01793 as a potential diagnostic biomarker of hepatitis B virus-related hepatocellular carcinoma.
Mo C; Wu J; Sui J; Deng Y; Li M; Cao Z; Hu Z; Huang J; Li S
Clin Biochem; 2022 Oct; 108():56-62. PubMed ID: 35760369
[TBL] [Abstract][Full Text] [Related]
12. Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances.
Zhang Y; Wang Y
Front Oncol; 2021; 11():667428. PubMed ID: 34055634
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
14. Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.
Ma LN; Liu XY; Lu ZH; Wu LG; Tang YY; Luo X; Hu YC; Yan TT; Wang Q; Ding XC; Xie Y
Oncol Lett; 2017 May; 13(5):3457-3464. PubMed ID: 28521452
[TBL] [Abstract][Full Text] [Related]
15. Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma.
Song S; Bai M; Li X; Gong S; Yang W; Lei C; Tian H; Si M; Hao X; Guo T
Expert Rev Mol Diagn; 2022 Mar; 22(3):361-378. PubMed ID: 35234564
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
Hou W; Bonkovsky HL
World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
[TBL] [Abstract][Full Text] [Related]
17. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.
Luo P; Wu S; Yu Y; Ming X; Li S; Zuo X; Tu J
Pathol Oncol Res; 2020 Apr; 26(2):599-603. PubMed ID: 30661224
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z
BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Potential of the Serum lncRNAs HOTAIR, BRM and ICR for Hepatocellular Carcinoma.
Lou ZH; Xu KY; Qiao L; Su XQ; Ou-Yang Y; Miao LB; Liu F; Wang Y; Fu A; Ren XH; Huang JS; Li ZY; Bao JF
Front Biosci (Landmark Ed); 2022 Sep; 27(9):264. PubMed ID: 36224021
[TBL] [Abstract][Full Text] [Related]
20. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.
Kienle P; Weitz J; Klaes R; Koch M; Benner A; Lehnert T; Herfarth C; von Knebel Doeberitz M
Arch Surg; 2000 Feb; 135(2):213-8. PubMed ID: 10668884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]